Whole genome sequencing analysis of esophageal cancers responding or non-responding to neo-adjuvant chemotherapy

被引：0
|
作者：
Dutta, Munmee [1 ]
Fujita, Masashi [2 ]
Yasuda, Tadashi [3 ]
Mateos, Raul Nicolas [1 ]
Patil, Ashwini
Nakai, Kenta [1 ]
Nakagawa, Hidewaki [2 ]
机构：
[1] Univ Tokyo, Dept Computat Biol & Med Sci, Tokyo, Japan
[2] RIKEN Ctr Integrat Med Sci, Wako, Saitama, Japan
[3] Kinki Univ, Sch Med, Dept Surg, Osaka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Esophageal squamous cell-carcinoma; Whole genome sequencing; Neo-adjuvant chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2049
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [1] Neo-adjuvant and adjuvant chronotherapy for the management of esophageal and gastric cancers
    不详
    [J]. CHRONOBIOLOGY INTERNATIONAL, 2005, 22 (06) : 1175 - 1176
  • [2] Neo-adjuvant chemotherapy of non-small cell lung cancers (NSCLC)
    Milleron, B
    Westeel, V
    Depierre, A
    [J]. PRESSE MEDICALE, 2002, 31 (17): : 797 - 801
  • [3] Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
    Findlay, John M.
    Castro-Giner, Francesc
    Makino, Seiko
    Rayner, Emily
    Kartsonaki, Christiana
    Cross, William
    Kovac, Michal
    Ulahannan, Danny
    Palles, Claire
    Gillies, Richard S.
    MacGregor, Thomas P.
    Church, David
    Maynard, Nicholas D.
    Buffa, Francesca
    Cazier, Jean-Baptiste
    Graham, Trevor A.
    Wang, Lai-Mun
    Sharma, Ricky A.
    Middleton, Mark
    Tomlinson, Ian
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [4] Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
    John M. Findlay
    Francesc Castro-Giner
    Seiko Makino
    Emily Rayner
    Christiana Kartsonaki
    William Cross
    Michal Kovac
    Danny Ulahannan
    Claire Palles
    Richard S. Gillies
    Thomas P. MacGregor
    David Church
    Nicholas D. Maynard
    Francesca Buffa
    Jean-Baptiste Cazier
    Trevor A. Graham
    Lai-Mun Wang
    Ricky A. Sharma
    Mark Middleton
    Ian Tomlinson
    [J]. Nature Communications, 7
  • [5] MRI is the best technique for monitoring cancers treated with neo-adjuvant chemotherapy
    Yeh, E.
    Slanetz, P.
    Kopans, D. B.
    Rafferty, E.
    Georgian-Smith, D.
    Moy, L.
    [J]. IMAGERIE DE LA FEMME, 2005, 15 (03) : 182 - 183
  • [6] Non-small cell lung cancer: Adjuvant and neo-adjuvant chemotherapy
    Brahmer, Julie R.
    Ettinger, David S.
    [J]. RESPIROLOGY, 2007, 12 (03) : 320 - 325
  • [7] Do lung cancers in initial studies benefit from neo-adjuvant chemotherapy?
    Bernardo, Wanderley Marques
    Barrichello, Adriana Paula De Castro
    Cecilio, Luiza Barros
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2007, 53 (04): : 286 - 287
  • [8] Early IRM evaluation of the response of breast cancers treated by neo-adjuvant chemotherapy
    Pierre, V
    Valentin, F.
    Debled, M.
    Boisserie-Lacroix, M.
    Brouste, V
    Asad-Syed, M.
    Hurtevent, G.
    Descat, E.
    Palussiere, J.
    Ferron, S.
    Kind, M.
    [J]. BULLETIN DU CANCER, 2009, 96 : S36 - S36
  • [9] Emerging Role of Whole Genome Sequencing in a Treatment Non Responding Extra-Pulmonary Tuberculosis
    Singh, S.
    Bargaje, M.
    Deoskar, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [10] Early identification of non-responding locally advanced breast tumors receiving neoadjuvant chemotherapy
    van de Giessen, Martijn
    Schaafsma, Boudewijn E.
    Charehbili, Ayoub
    Smit, Vincent T. H. B. M.
    Kroep, Judith R.
    Lelieveldt, Boudewijn P. F.
    Liefers, Gerrit-Jan
    Chan, Alan
    Lowik, Clemens W. G. M.
    Dijkstra, Jouke
    van de Velde, Cornelis J. H.
    Wasser, Martin N. J. M.
    Vahrmeijer, Alexander L.
    [J]. PHOTONIC THERAPEUTICS AND DIAGNOSTICS XI, 2015, 9303
12345